Cargando…

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

Cancer cachexia is a wasting condition, driven by systemic inflammation and oxidative stress. This study investigated eicosapentaenoic acid (EPA) in combination with oxypurinol as a treatment in a mouse model of cancer cachexia. Mice with cancer cachexia were randomized into 4 treatment groups (EPA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaughan, Vanessa C., Sullivan-Gunn, Melanie, Hinch, Edward, Martin, Peter, Lewandowski, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447801/ https://www.ncbi.nlm.nih.gov/pubmed/23029301 http://dx.doi.org/10.1371/journal.pone.0045900

Ejemplares similares

Cancer cachexia: impact, mechanisms and emerging treatments
por: Vaughan, Vanessa C., et al.
Publicado: (2012)

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration
por: Stamp, Lisa K., et al.
Publicado: (2019)

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
por: Murphy, R A, et al.
Publicado: (2011)

Choosing a stable housekeeping gene and protein is essential in generating valid gene and protein expression results
por: Sullivan-Gunn, M, et al.
Publicado: (2011)

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
por: Penna, Fabio, et al.
Publicado: (2011)

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics
por: Hishe, Hailemichael Z., et al.
Publicado: (2022)

Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice
por: Hinch, E. C. A., et al.
Publicado: (2013)

Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation
por: Orriss, Isabel R., et al.
Publicado: (2016)

Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase
por: Sekine, Mai, et al.
Publicado: (2023)

Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia
por: Pedroso, Felipe E., et al.
Publicado: (2012)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Mathematical Model of Muscle Wasting in Cancer Cachexia
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2020)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

Oxypurinol protects renal ischemia/reperfusion injury via heme oxygenase-1 induction
por: Kang, Hye Bin, et al.
Publicado: (2023)

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
por: Hindi, Jessica, et al.
Publicado: (2023)

Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia
por: Ojima, Chiharu, et al.
Publicado: (2020)

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1
por: Tao, Weili, et al.
Publicado: (2023)

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
por: Ochi, Eisuke, et al.
Publicado: (2018)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020)

Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia
por: Rausch, Valentina, et al.
Publicado: (2021)

β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy
por: Kim, Yerin, et al.
Publicado: (2023)

Individual variation and intraclass correlation in arachidonic acid and eicosapentaenoic acid in chicken muscle
por: Haug, Anna, et al.
Publicado: (2010)

Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
por: Vora, Bianca, et al.
Publicado: (2021)

Plasma Eicosapentaenoic Acid Is Associated with Muscle Strength and Muscle Damage after Strenuous Exercise
por: Ochi, Eisuke, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates
por: Chu, Wan-Yu, et al.
Publicado: (2021)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Lenk, Karsten, et al.
Publicado: (2010)

The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice
por: Di Marco, Sergio, et al.
Publicado: (2012)

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
por: Bowen, T Scott, et al.
Publicado: (2015)

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia
por: Damrauer, Jeffrey S., et al.
Publicado: (2018)

The role of microRNA in cancer cachexia and muscle wasting: A review article
por: Sutandyo, Noorwati
Publicado: (2021)

The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia
por: Cheung, Wai W., et al.
Publicado: (2021)

Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia
por: Zhang, Zhige, et al.
Publicado: (2023)

MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia
por: Marceca, Gioacchino P., et al.
Publicado: (2020)

HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c8eeuig5ch0j0qfer3nd9h9ud8